title: Platelet antiaggregants in stroke prevention.
abstract: Antiplatelet agents are one of the main interventions for recurrent ischemic stroke prevention. Their time of use, dosage, and combination of therapy have different effects in terms of stroke risk reduction and adverse effects. This review provides an evidence-based update of the latest on antiplatelet therapy for stroke prevention.
authors.affiliation: Neurology Department, Stritch School of Medicine, Loyola University Chicago, 2160 South 1st Avenue, Building 105, Room 2700, Maywood, IL 60153, USA. smoralesvidal@lumc.edu
authors.forename: Sarkis G
authors.initials: SG
authors.lastname: Morales Vidal
authors.forename: Sean
authors.initials: S
authors.lastname: Ruland
mesh_terms: D000818:Animals; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*
chemical_list: D010975:Platelet Aggregation Inhibitors
keywords: Antiplatelet; Aspirin; Cilostazol; Clopidogrel; Dypiridamole; Hemorrhage; Stroke